Depression Treatment in General Medical Setting

一般医疗环境中的抑郁症治疗

• 批准号: 7277170
• 负责人: MILDRED VERA
• 金额: $ 20.26万
• 依托单位: UNIVERSITY OF PUERTO RICO MED SCIENCES
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/7277170
• 关键词: Puerto Rican; behavioral /social science research tag; clinical depression; clinical research; functional ability; human subject; human therapy evaluation; longitudinal human study; patient oriented research; primary care physician; psychotherapy; quality of life

Clinically depressed individuals that could benefit from newer treatments for depression often do not receive care. Low treatment rates are of particular concern since depression is projected to be the second leading cause of disability worldwide by 2010. Major depression has been the focus of numerous intervention studies with primary care patients during recent years. However, despite advances in the development and testing of quality intervention models for depression treatment, very little is known about the effectiveness of interventions with Latinos. This is important because Latinos are less likely than whites to receive depression treatment, even though the rates of depression are similar for both groups. A major public health challenge is to make available the benefits of intervention developments in depression treatment for all groups in society. As a first step, this application seeks support to examine the impact of a quality depression intervention with Puerto Ricans. The specific aims are: 1. To examine the effect of a Collaborative Depression Management Program in reducing depressive symptoms, improving quality of life, and decreasing health-related functional impairment among Puerto Rican patients in general medical settings. 2. To determine whether a Collaborative Depression Management Program is effective in improving satisfaction with care and reducing barriers to depression treatment among Puerto Rican patients in general medical settings. This study will employ a randomized experimental design. Depressed patients receiving general medical care will be assigned to one of two conditions: 80 to the Depression Management Program and 80 to treatment as usual. All subjects will complete assessments at baseline, week 8, week 16, and week 24. Our overall programmatic goals are to increase the likelihood that depressed patients receive care and to make available for the Puerto Rican community advances in the treatment of major depression.

可以从新的抑郁症治疗中受益的临床抑郁症患者通常得不到护理。低治疗率尤其值得关注，因为抑郁症预计到 2010 年将成为全球第二大残疾原因。近年来，重度抑郁症一直是针对初级保健患者的众多干预研究的焦点。然而，尽管抑郁症治疗质量干预模型的开发和测试取得了进展，但人们对拉丁裔干预措施的有效性知之甚少。这很重要，因为拉丁裔比白人接受抑郁症治疗的可能性更低，尽管这两个群体的抑郁症发生率相似。重大公共卫生挑战 的目标是让社会所有群体都能受益于抑郁症治疗干预措施的发展。作为第一步，该申请寻求支持，以检查高质量抑郁症干预措施对波多黎各人的影响。具体目标是： 1. 检验协作抑郁管理计划在一般医疗环境中波多黎各患者减轻抑郁症状、改善生活质量和减少健康相关功能障碍方面的效果。 2. 确定协作抑郁症管理计划是否能有效提高波多黎各患者在一般医疗环境中的护理满意度并减少抑郁症治疗的障碍。 本研究将采用随机实验设计。接受一般医疗护理的抑郁症患者将被分配到以下两种情况之一：80 名接受抑郁症管理计划，80 名接受照常治疗。所有受试者都将在基线、第 8 周、第 16 周和第 24 周完成评估。我们的总体计划目标是增加抑郁症患者接受护理的可能性，并为波多黎各社区提供重度抑郁症治疗方面的进展。